David C. Hohn, Director at CLEVELAND BIOLABS INC (CBLI), bought 1,000 shares at $1.61 ($2K) on 2012-07-02, disclosed to the SEC on 2012-07-05.
Scheduled purchase ($2k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CBLI | BUY | 2011-10-06 | $2K | — | Filing → |